These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 23295950

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster.
    Yang X, Haurigot V, Zhou S, Luo G, Couto LB.
    Hepatology; 2010 Dec; 52(6):1877-87. PubMed ID: 20931557
    [Abstract] [Full Text] [Related]

  • 3. Successful disabling of the 5' UTR of HCV using adeno-associated viral vectors to deliver modular multimeric primary microRNA mimics.
    Bourhill T, Arbuthnot P, Ely A.
    J Virol Methods; 2016 Sep; 235():26-33. PubMed ID: 27181212
    [Abstract] [Full Text] [Related]

  • 4. Regulation of the hepatitis C virus genome replication by miR-199a.
    Murakami Y, Aly HH, Tajima A, Inoue I, Shimotohno K.
    J Hepatol; 2009 Mar; 50(3):453-60. PubMed ID: 19144437
    [Abstract] [Full Text] [Related]

  • 5. Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.
    Thibault PA, Wilson JA.
    Pharmacol Res; 2013 Sep; 75():48-59. PubMed ID: 23541631
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of hepatitis C virus replication by miR-196a using lentiviral vectors.
    Shafaati M, Jamalidoust M, Kargar M, Arefian E, Kafilzadeh F.
    Microbiol Immunol; 2021 Apr; 65(4):161-170. PubMed ID: 33470443
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model.
    Suhy DA, Kao SC, Mao T, Whiteley L, Denise H, Souberbielle B, Burdick AD, Hayes K, Wright JF, Lavender H, Roelvink P, Kolykhalov A, Brady K, Moschos SA, Hauck B, Zelenaia O, Zhou S, Scribner C, High KA, Renison SH, Corbau R.
    Mol Ther; 2012 Sep; 20(9):1737-49. PubMed ID: 22735378
    [Abstract] [Full Text] [Related]

  • 9. Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver.
    Qiao C, Yuan Z, Li J, He B, Zheng H, Mayer C, Li J, Xiao X.
    Gene Ther; 2011 Apr; 18(4):403-10. PubMed ID: 21150938
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA.
    Sakamoto N, Tanabe Y, Yokota T, Satoh K, Sekine-Osajima Y, Nakagawa M, Itsui Y, Tasaka M, Sakurai Y, Cheng-Hsin C, Yano M, Ohkoshi S, Aoyagi Y, Maekawa S, Enomoto N, Kohara M, Watanabe M.
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1437-47. PubMed ID: 17683479
    [Abstract] [Full Text] [Related]

  • 11. Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway.
    Ishida H, Tatsumi T, Hosui A, Nawa T, Kodama T, Shimizu S, Hikita H, Hiramatsu N, Kanto T, Hayashi N, Takehara T.
    Biochem Biophys Res Commun; 2011 Aug 19; 412(1):92-7. PubMed ID: 21802413
    [Abstract] [Full Text] [Related]

  • 12. Ribozyme gene therapy for hepatitis C virus infection.
    Welch PJ, Yei S, Barber JR.
    Clin Diagn Virol; 1998 Jul 15; 10(2-3):163-71. PubMed ID: 9741642
    [Abstract] [Full Text] [Related]

  • 13. Transduction with Lentiviral Vectors Altered the Expression Profile of Host MicroRNAs.
    Huang H, Zhang C, Wang B, Wang F, Pei B, Cheng C, Yang W, Zhao Z.
    J Virol; 2018 Sep 15; 92(18):. PubMed ID: 29997205
    [Abstract] [Full Text] [Related]

  • 14. Characterization of miR-122-independent propagation of HCV.
    Ono C, Fukuhara T, Motooka D, Nakamura S, Okuzaki D, Yamamoto S, Tamura T, Mori H, Sato A, Uemura K, Fauzyah Y, Kurihara T, Suda T, Nishio A, Hmwe SS, Okamoto T, Tatsumi T, Takehara T, Chayama K, Wakita T, Koike K, Matsuura Y.
    PLoS Pathog; 2017 May 15; 13(5):e1006374. PubMed ID: 28494029
    [Abstract] [Full Text] [Related]

  • 15. Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus.
    Fukuhara T, Kambara H, Shiokawa M, Ono C, Katoh H, Morita E, Okuzaki D, Maehara Y, Koike K, Matsuura Y.
    J Virol; 2012 Aug 15; 86(15):7918-33. PubMed ID: 22593164
    [Abstract] [Full Text] [Related]

  • 16. Suppression of hepatitis C virus replicon by adenovirus vector-mediated expression of tough decoy RNA against miR-122a.
    Sakurai F, Furukawa N, Higuchi M, Okamoto S, Ono K, Yoshida T, Kondoh M, Yagi K, Sakamoto N, Katayama K, Mizuguchi H.
    Virus Res; 2012 May 15; 165(2):214-8. PubMed ID: 22342424
    [Abstract] [Full Text] [Related]

  • 17. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D, Korf M, Beger C, Manns MP, Krüger M.
    FEBS J; 2005 Nov 15; 272(22):5910-22. PubMed ID: 16279954
    [Abstract] [Full Text] [Related]

  • 18. MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy.
    Gupta A, Swaminathan G, Martin-Garcia J, Navas-Martin S.
    Viruses; 2012 Oct 26; 4(11):2485-513. PubMed ID: 23202492
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
    Mukherjee A, Di Bisceglie AM, Ray RB.
    J Virol; 2015 Mar 26; 89(6):3356-65. PubMed ID: 25589644
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.